Ignite Creation Date:
2024-05-06 @ 8:19 PM
Last Modification Date:
2024-10-26 @ 3:25 PM
Study NCT ID:
NCT06344715
Status:
RECRUITING
Last Update Posted:
2024-04-03
First Post:
2024-03-19
Brief Title:
Phase 1 Study Evaluating Safety and Tolerability of SL-T10 GX-I7 and Pembrolizumab Triple Combination in mCRPC
Sponsor:
Organization:
SL VAXiGEN